» Authors » Tae Woo Park

Tae Woo Park

Explore the profile of Tae Woo Park including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 624
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Shuey B, Joudrey P, Anderson T, Park T, Liebschutz J
J Gen Intern Med . 2024 Oct; PMID: 39358500
No abstract available.
2.
Xu K, Nascimento F, Lin B, Park T, Maust D, Samples H, et al.
BMJ Neurol Open . 2024 Sep; 6(2):e000767. PMID: 39315391
Background: Characterising benzodiazepine (BZD) prescribing to individuals with psychogenic non-epileptic seizures (PNES) is important for optimising PNES outcomes, but existing data is lacking. Methods: Using a nationwide administrative claims database...
3.
Park T, Shuey B, Liebschutz J, Cantor J, Anderson T
JAMA . 2024 Jul; 332(6):502-504. PMID: 38990551
No abstract available.
4.
Al Faysal J, Noor-E-Alam M, Young G, Lo-Ciganic W, Goodin A, Huang J, et al.
Comput Biol Med . 2024 Jun; 177:108493. PMID: 38833799
Objectives: Buprenorphine is an effective evidence-based medication for opioid use disorder (OUD). Yet premature discontinuation undermines treatment effectiveness, increasing the risk of mortality and overdose. We developed and evaluated a...
5.
Kim S, Cho M, Chun S, Park T, Joo J, Koo Y, et al.
Obstet Gynecol Sci . 2024 Feb; 67(3):304-313. PMID: 38368852
Objective: This study aimed to determine the clinical advantage of spindle-view intracytoplasmic sperm injection (SVICSI; a novel technology) over conventional intracytoplasmic sperm injection (cICSI) in patients with poor ovarian response...
6.
Choi Y, Choe H, Kook M, Choo S, Park T, Bae S, et al.
J Med Chem . 2023 Dec; 67(3):1825-1842. PMID: 38124427
The outer membrane (OM) of Gram-negative bacteria is the most difficult obstacle for small-molecule antibiotics to reach their targets in the cytosol. The molecular features of Gram-negative antibiotics required for...
7.
Park T, Baul T, Morgan J, Wilens T, Yule A
Psychiatr Serv . 2023 Oct; 75(3):214-220. PMID: 37789727
Objective: This study aimed to assess nationwide trends in attention-deficit hyperactivity disorder (ADHD) diagnoses and pharmacotherapy among patients with opioid use disorder and ADHD and to examine factors predicting receipt...
8.
Wang Y, Wilson D, Fernandes D, Adkins L, Bantad A, Copacia C, et al.
J Clin Med . 2023 Mar; 12(5). PMID: 36902574
While the Food and Drug Administration's black-box warnings caution against concurrent opioid and benzodiazepine (OPI-BZD) use, there is little guidance on how to deprescribe these medications. This scoping review analyzes...
9.
Peterkin A, Jawa R, Menezes K, You J, Cabral H, Ruiz-Mercado G, et al.
Subst Use Misuse . 2023 Jan; 58(4):585-589. PMID: 36695079
Background: The COVID-19 pandemic drove significant disruptions in access to substance use disorder (SUD) treatment and harm reduction services. Healthcare delivery via telemedicine has increasingly become the norm, rendering access...
10.
Bagley S, Schoenberger S, dellaBitta V, Lunze K, Barron K, Hadland S, et al.
J Adolesc Health . 2022 Oct; 72(1):105-110. PMID: 36216678
Purpose: Young adults with opioid use disorder (OUD) have low engagement in treatment with medication for opioid use disorder (MOUD). The objective of this study is to explore the beliefs...